Sandrine Lecour1, Peter Owira, Lionel H Opie
1Hatter Institute for Cardiology Research, Department of Medicine, University of Cape Town Medical School, Cape Town, South Africa. Sandrine@capeheart.uct.ac.za
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Low-dose ceramide protects the heart from ischemia/reperfusion injury by preconditioning. This cardioprotective effect is mediated by reactive oxygen species (ROS) production, highlighting a novel therapeutic mechanism.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: